Andlauer Healthcare Group Inc
OTC:ANDHF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Andlauer Healthcare Group Inc
OTC:ANDHF
|
CA |
|
R
|
Renasant Corp
XBER:RN6
|
US |
|
Haypp Group AB (publ)
F:8QG0
|
SE |
|
L
|
London Stock Exchange Group PLC
F:LS4C
|
UK |
|
J
|
JCDecaux SE
SWB:DCS
|
FR |
|
M
|
Meta Platforms Inc
XMUN:FB2A
|
US |
|
P
|
Persimmon PLC
F:OHP
|
UK |
|
R
|
Renasant Corp
F:RN6
|
US |
|
B
|
Berkshire Hathaway Inc
DUS:BRH
|
US |
|
Centessa Pharmaceuticals PLC
LSE:0ACX
|
UK |
|
Tharisa PLC
LSE:THS
|
CY |
|
L
|
London Stock Exchange Group PLC
XBER:LS4C
|
UK |
|
Eagle Materials Inc
NYSE:EXP
|
US |
|
C
|
Cigna Corp
LSE:0A77
|
US |
|
F
|
Fortress Biotech Inc
F:CNB
|
US |
|
K
|
Kering SA
XHAM:PPX
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ANDHF's stock price target?
Not Available
ANDHF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Andlauer Healthcare Group Inc?
Projected CAGR
2%
Over the last 7 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Andlauer Healthcare Group Inc?
Projected CAGR
7%
Over the last 7 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 7%.